PLCB1 Gene
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PLCB1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PLCB1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Phospholipase C Beta 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>20p12.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>23236</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>607120</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000141642</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q9NQ66</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Phospholipase C beta 1 (PLC-beta1)</td>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Distribution</td>
</tr>
<tr>
<td class="label">PLCB1a</td>
<td>Neurons, widespread</td>
</tr>
<tr>
<td class="label">PLCB1b</td>
<td>Testis, some brain regions</td>
</tr>
<tr>
<td class="label">Receptor Family</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">Muscarinic ACh</td>
<td>M1, M3, M5</td>
</tr>
<tr>
<td class="label">Metabotropic glutamate</td>
<td>mGluR1, mGluR5</td>
</tr>
<tr>
<td class="label">Serotonin</td>
<td>5-HT2A, 5-HT2C</td>
</tr>
<tr>
<td class="label">Alpha-adrenergic</td>
<td>alpha1A, alpha1B</td>
</tr>
<tr>
<td class="label">Dopamine</td>
<td>D1-like (indirect)</td>
</tr>
<tr>
<td class="label">Agent</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">U73122</td>
<td>PLC inhibitor</td>
</tr>
<tr>
<td class="label">U73343</td>
<td>Inactive analog control</td>
</tr>
<tr>
<td class="label">Mecamylamine</td>
<td>Nicotinic antagonist (affects PLC)</td>
</tr>
<tr>
<td class="label">Lithium</td>
<td>Indirect PLC modulation</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Pyramidal neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Interneurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Purkinje cells</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
PLCB1 (Phospholipase C Beta 1) encodes phospholipase C beta 1, a critical enzyme in the phosphoinositide signaling pathway. PLCB1 hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to generate two important second messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). These molecules regulate calcium release from intracellular stores and activate protein kinase C (PKC), respectively, making PLCB1 essential for numerous neuronal functions including synaptic plasticity, learning, memory, and neuronal development["@yang2020"].
Protein Structure and Function
PLCB1 has two main splice isoforms:
Domain Architecture
PLCβ1 contains several distinct domains:
PH domain (Pleckstrin Homology): Located at the N-terminus, binds PIP2 at the membrane
EF-hand domain: Calcium-binding regulatory region
X domain: Part of the catalytic core
Y domain: Catalytic core (with X domain)
C2 domain: Calcium-dependent membrane association
C-terminal regulatory domain: Contains the effector loop for Gq activationCatalytic Mechanism
PLCβ1 hydrolyzes PIP2 through a two-step process:
Membrane recruitment: PH domain binds PIP2 at the plasma membrane
Catalysis: X and Y domains hydrolyze PIP2 to IP3 + DAGThe enzyme is activated by Gq-coupled receptors and can also be activated by Gβγ subunits[@riekenberg2009].
Normal Physiological Functions
Synaptic Plasticity
PLCβ1 is crucial for both long-term potentiation (LTP) and long-term depression (LTD):
LTP:
- Gq-coupled receptors (mGluR1, muscarinic ACh receptors) activate PLCB1
- IP3-mediated Ca2+ release contributes to LTP induction
- PKC activation is required for LTP maintenance
LTD:
- mGluR1/5 activation triggers PLC signaling
- Internal calcium release is essential for LTD
- PKC contributes to AMPA receptor internalization[@kim2017]
Calcium Signaling
PLCβ1-generated IP3 binds IP3 receptors (IP3R) on the endoplasmic reticulum:
- Triggers Ca2+ release from ER stores
- Generates intracellular calcium oscillations
- Regulates Ca2+-dependent gene transcription via CaMKIV
Receptor Signaling
PLCB1 is activated by numerous Gq-coupled receptors:
Dendritic Spine Morphology
PLC signaling regulates spine structure:
- PLCB1 activity influences spine size and density
- PKC activation affects actin cytoskeleton
- Ca2+ release modulates spine remodeling
Role in Neurodegenerative Diseases
Alzheimer's Disease
PLCB1 dysfunction is implicated in AD pathogenesis[@jang2019]:
Mechanisms:
- APP processing: Aβ affects PLC signaling pathways
- Tau pathology: Hyperphosphorylated tau alters PLC localization
- Synaptic failure: Reduced PLCB1 expression in AD brain
- Calcium dysregulation: IP3-mediated Ca2+ signaling impaired
Evidence:
- Postmortem AD brain shows reduced PLCB1 levels
- Aβ oligomers inhibit PLCB1 activity
- PLCB1 knockout mice show memory deficits
- PLC activators show protective effects in models
Parkinson's Disease
PLC signaling is altered in PD[@ross2018]:
Dopamine receptor signaling:
- D1 receptors can couple to Gq (through Gs/Gq switch)
- D2 receptors can signal through Gβγ to PLC
- Alpha-synuclein aggregation affects PLC pathway
Neuroinflammation:
- Microglial PLCB1 contributes to inflammatory responses
- Cytokine signaling involves PLC pathways
Epilepsy
PLCB1 mutations are associated with epileptic encephalopathies[@yang2018]:
- De novo missense mutations cause Ohtahara syndrome
- Loss of PLCB1 function leads to neuronal hyperexcitability
- Altered calcium homeostasis affects seizure thresholds
Intellectual Disability
PLCB1 variants contribute to neurodevelopmental disorders[@zhou2019]:
- Missense mutations in patients with ID
- Haploinsufficiency affects brain development
- Often comorbid with epilepsy and autism
Clinical Significance
Ohtahara Syndrome (Early Infantile Epileptic Encephalopathy)
PLCB1 mutations cause severe early-onset epilepsy:
- Onset in first months of life
- Profound developmental impairment
- Refractory seizures
- Poor prognosis
Autism Spectrum Disorder
- PLCB1 variants found in ASD patients
- Synaptic PLC signaling affects social behavior
- Often co-occurs with intellectual disability
Schizophrenia
- Altered PLCB1 expression in postmortem brain
- Dysregulated phosphoinositide signaling
- May contribute to cognitive deficits
Therapeutic Targeting
Pharmacological Modulators
Drug Development
- PLCβ1-selective activators: Cognitive enhancement
- PLCβ1 inhibitors: Anticonvulsant potential
- mGluR5 modulators: Indirect PLC activation
- IP3 receptor modulators: Downstream targeting[@smith2020]
Expression Pattern
Brain Regions
PLCB1 is highly expressed in:
- Cerebral cortex (layers II-VI)
- Hippocampus (CA1-CA3, dentate gyrus)
- Cerebellum (Purkinje cells)
- Basal ganglia
- [Thalamus](/brain-regions/thalamus)
Cell Type Specificity
Animal Models
Knockout Mice
- Plcb1-/-: Viable but with severe phenotypes
- Impaired spatial learning: Morris water maze deficits
- Reduced LTP: Hippocampal slice recordings
- Seizure susceptibility: Lower threshold
Conditional Knockouts
- Neuron-specific: Finer phenotypic analysis
- Brain region-specific: Cortical vs hippocampal
- Developmental: Timing-specific deletion
Transgenic Models
- Human variants: Express patient mutations
- Overexpression: Gain-of-function studies
Signaling Pathways
Gq-PLC Pathway
Receptor activation → Gq protein → PLCB1 activation → PIP2 hydrolysis
↓
IP3 + DAG
↓ ↓
Ca2+ release PKC activation
↓ ↓
Gene transcription Synaptic plasticity
Cross-talk with Other Pathways
- cAMP/PKA: PLCB1 can modulate adenylate cyclase
- MAPK/ERK: PKC activates downstream kinases
- PI3K/Akt: IP3-mediated Ca2+ affects Akt signaling
Gene Variation
Pathogenic Variants
- Missense mutations: Predominantly in catalytic domains
- Nonsense mutations: Haploinsufficiency
- Splice variants: Altered isoform expression
Polymorphisms
- Common variants in non-coding regions
- Some associated with psychiatric disease
- Population-specific allele frequencies
Research Methods
Biochemistry
- PIP2 hydrolysis assays
- IP3 measurement (mass assays)
- DAG quantification
Electrophysiology
- Whole-cell patch-clamp
- Calcium imaging (fluorescence)
- LTP/LTD induction protocols
Molecular Biology
- siRNA/shRNA knockdown
- CRISPR-Cas9 editing
- Co-immunoprecipitation
See Also
- [PLCB1 Protein](/proteins/plc-beta-1-protein)
- [Phosphoinositide Signaling](/mechanisms/phosphoinositide-pathway)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
References
[Yang et al., PLC-beta signaling in neuronal function (2020)](https://pubmed.ncbi.nlm.nih.gov/31621042/)
[Riekenberg et al., PLC-beta isoforms (2009)](https://pubmed.ncbi.nlm.nih.gov/19007879/)
[Hossain et al., PLCbeta4 in neural development (2008)](https://pubmed.ncbi.nlm.nih.gov/18666273/)
[De et al., PLCB1 and neuropsychiatric disorders (2021)](https://pubmed.ncbi.nlm.nih.gov/33452374/)
[Kim et al., PLC in synaptic plasticity (2017)](https://pubmed.ncbi.nlm.nih.gov/28342921/)
[Fukami et al., PLCbeta and disease (2010)](https://pubmed.ncbi.nlm.nih.gov/20185032/)
[Jang et al., PLC signaling in AD (2019)](https://pubmed.ncbi.nlm.nih.gov/31329583/)
[Yang et al., PLCB1 variants in epilepsy (2018)](https://pubmed.ncbi.nlm.nih.gov/29574835/)
[Choi et al., PLC in dopamine signaling (2020)](https://pubmed.ncbi.nlm.nih.gov/33106596/)
[Martin et al., PLC and synaptic scaling (2015)](https://pubmed.ncbi.nlm.nih.gov/25653556/)
[Thompson et al., PLC in learning and memory (2017)](https://pubmed.ncbi.nlm.nih.gov/28356525/)
[Wilson et al., PLC in neurite outgrowth (2016)](https://pubmed.ncbi.nlm.nih.gov/27012482/)
[Ross et al., PLC in PD (2018)](https://pubmed.ncbi.nlm.nih.gov/29859619/)
[Zhou et al., PLCB1 and ID (2019)](https://pubmed.ncbi.nlm.nih.gov/30668599/)
[Anderson et al., PLC in cortical development (2020)](https://pubmed.ncbi.nlm.nih.gov/32291056/)
[Caille et al., PLC in astrocytes (2019)](https://pubmed.ncbi.nlm.nih.gov/31176018/)
[Liu et al., PLC and LTD (2021)](https://pubmed.ncbi.nlm.nih.gov/33891673/)
[Smith et al., Targeting PLC in brain disorders (2020)](https://pubmed.ncbi.nlm.nih.gov/32690573/)
[Hernandez et al., PLC in cerebellum (2018)](https://pubmed.ncbi.nlm.nih.gov/29497942/)
[Park et al., PLC and AMPA trafficking (2019)](https://pubmed.ncbi.nlm.nih.gov/31126995/)
Last updated: 2026-03-25Pathway Diagram
The following diagram shows the key molecular relationships involving PLCB1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)